Does LVAD implantation improve mitral regurgitation, and does baseline or residual MR influence outcomes?
LVAD implantation, particularly with the HM3 device, effectively reduces mitral regurgitation, and neither baseline nor residual MR negatively impacts patient outcomes.
Hemodynamic unloading after LVAD implantation improves clinically significant MR early, sustainably, and to a greater extent with the HM3 LVAD. Neither baseline nor residual MR influence outcomes after LVAD implantation.
Kanwar et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: